Association between levels of physical activity and use of medication among older women;Associação entre nível de atividade física e uso de medicamentos entre mulheres idosas

Cadernos de Saude Publica

Volumn 28, Issue 3, 2012, Pages 463-471

  da Silva, Leonardo José ^a,b   Azevedo, Mario Renato ^c   Matsudo, Sandra ^b   Lopes, Guiomar Silva ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Study Center of the Laboratório de Aptidão Física de São Caetano do Sul   (Brazil)

^c FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

Aging; Drugs; Physical activity

Indexed keywords

AGE; AGED; ARTICLE; BRAZIL; DRUG THERAPY; EXERCISE; FEMALE; HUMAN; MIDDLE AGED; PHYSIOLOGY; POISSON DISTRIBUTION; SOCIOECONOMICS; TIME; UTILIZATION REVIEW;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAZIL; DRUG THERAPY; EXERCISE; FEMALE; HUMANS; MIDDLE AGED; POISSON DISTRIBUTION; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 84858398628     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2012000300006     Document Type: Article

References (34)

1. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.
2. World Health Organization. Global strategy on diet, physical activity and health. Geneva: World Health Organization; 2004.
3. Artinian NT, Fletcher GF, Mozaffarian D, Kris- Etherton P, Van Horn L, Lichtenstein AH, et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults. A scientific statement from the American Heart Association. Circulation 2010; 122:406-41.
4. Mazo G, Mota J, Gonçalves L, Matos M. Nível de atividade física, condições de saúde e características sócio-demográficas de mulheres idosas brasileiras. Rev Port Ciênc Desporto 2005; 5:202-12.
5. Hallal PC, Victora CG, Wells JCK, Lima RC. Physical inactivity: prevalence and associated variables in Brazilian adults. Med Sci Sports Exerc 2003; 35:1894-900.
6. Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med 1997; 336:1269-75.
7. Oldridge NB. Economic burden of physical inactivity: healthcare costs associated with cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2008; 15:130-9.
8. Wang W, McGreevey WP, Fu C. Type 2 diabetes mellitus in China: a preventable economic burden. Am J Manag Care 2009; 15:593-601.
9. Neutel CI. Drug utilization patterns as indicators. Pharmacoepidemiol Drug Saf 1998; 7:131-3.
10. Anderson LH, Martinson BC, Crain AL, Pronk NP, Whitebird RR, Fine LJ, et al. Health care charges associated with physical inactivity, overweight, and obesity. Prev Chronic Dis 2005; 2:1-12.
11. Pillman BCS, Ubitz JL. The effect of longevity on spending for acute and long-term care. N Engl J Med 2000; 342:1409-15.
12. Rolim LMC, Amaral SL, Monteiro HL. Hipertensão e exercício: custos do tratamento ambulatorial, antes e após a adoção da prática regular e orientada de condicionamento físico. Hipertensão 2007; 10:54-61.
13. Departamento de Atenção Básica, Secretaria de Políticas de Saúde, Ministério da Saúde. Programa Saúde da Família. Rev Saúde Pública 2000; 34:316-9.
14. Nelson MF, Rejeski J, Blair SN, Duncan PW, Judge JO, King AC, et al. Physical activity and public health in older adults. Recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116:2-12.
15. Haskell WL, Lee I-M, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116:1081-93.
16. Silva L, Matsudo S, Lopes G. Do diagnóstico à ação: Programa comunitário de atividade física na atenção básica: a experiência do município de São Caetano do Sul, Brasil. Rev Bras Ativ Fís Saúde 2011; 16:84-8.
17. Tudor-Locke C, Lind K, Reis JP, Ainsworth BE, Macera CA. A preliminary evaluation of a pedometerassessed physical activity self-monitoring survey. Field Methods 2004; 16:422-38.
18. Masurier G. Walk which way? ACSM'S Health & Fitness Journal 2004; 8:7-10.
19. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003; 3:21-33.
20. Dumith SC. Proposta de um modelo teórico para a adoção da prática de atividade física. Rev Bras Ativ Fís Saúde 2008; 13:110-20.
21. Bertoldi AD, Hallal PC, Barros AJD. Physical activity and medicine use: evidence from a population-based study. BMC Public Health 2006; 6:224-9.
22. Barengo N, Hu G, Kastarinen M, Lakka TA, Pekkarinen H, Nissinen A, et al. Low physical activity as a predictor for antihypertensive drug treatment in 25-64-year-old populations in Eastern and southwestern Finland. J Hypertens 2005; 23:293-9.
23. Bond V, Franks BD, Tearney RJ, Wood B, Melendez MA, Johnson L. Exercise blood pressure response and skeletal muscle vasodilator capacity in normotensives with positive and negative family history of hypertension. J Hypertens 1994; 12:285-90.
24. Dubbert PM, Martin JE, Cushman WC, Meydrech EF, Carroll RG. Endurance exercise in mild hypertension: effects on blood pressure and associated metabolic and quality of life variables. J Hum Hypertens 1994; 8:265-72.
25. Arakawa K. Antihypertensive mechanism of exercise. J Hypertens 1993; 11:223-9.
26. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998; 98:2709-15.
27. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000; 342:454-60.
28. Bertoldi AD, Barros AJ, Hallal PC, Lima RC. Drug utilization in adults: prevalence and individuals determinants. Rev Saúde Pública 2004; 38:228-38.
29. Williams PT. Relationship of running intensity to hypertension, hypercholesterolemia, and diabetes. Med Sci Sports Exerc 2004; 40:1740-8.
30. Ungar W. Bias - It's everywhere! A commentary on the impact of bias and the assessment of agreement in the measurement of medication use in epidemiology research. Pharmacoepidemiol Drug Saf 1998; 7:425-7.
31. Heesch KC, van Uffelen JGZ, Hill RL, Brown WJ. What do IPAQ questions mean to older adults? Lessons from cognitive interviews. Int J Behav Nutr Phys Act 2010; 7:35-48.
32. Hallal PC, Gómez LF, Parra DC, Lobelo F, Mosquera J, Florindo AA, et al. Lessons learned after 10 years of IPAQ use in Brazil and Colombia. J Phys Act Health 2010; 7 Suppl 2:259-64.
33. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: a systematic review and meta-analysis. BMJ 2007; 334:299-308.
34. Slentz CA, Houmard JA, Kraus WE. Modest exercise prevents the progressive disease associated with physical inactivity. Exerc Sport Sci Rev 2007; 35: 18-23.